Floatz logo

MACROGOLS

Rectum Neoplasm

Helsinki University Central HospitalmixturePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Rectum Neoplasm cohort.

Asset / SponsorPhaseRating
METRONIDAZOLE
Helsinki University Central Hospital
Phase 4BB
(±)-TRAMADOL
University of Illinois College of Medicine at Peoria
Phase 4BB
NEPENTHE
University of Illinois College of Medicine at Peoria
Phase 4BB
NEOMYCIN
Helsinki University Central Hospital
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
University of Illinois College of Medicine at Peoria
Phase 4BB

View all 14 →

Same molecule, other indications

MACROGOLS is also rated in:

inflammatory bowel diseaseDormant
A
Indicative ·
81 / 100
View asset →
polyp of colonDormant
BBB
Indicative ·
75 / 100
View asset →
Surgical Site InfectionDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →